Literature DB >> 23553155

Intake of trans fat and all-cause mortality in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) cohort.

James N Kiage1, Peter D Merrill, Cody J Robinson, Yue Cao, Talha A Malik, Barrett C Hundley, Ping Lao, Suzanne E Judd, Mary Cushman, Virginia J Howard, Edmond K Kabagambe.   

Abstract

BACKGROUND: A high intake of trans fatty acids decreases HDL cholesterol and is associated with increased LDL cholesterol, inflammation, diabetes, cancer, and mortality from cardiovascular disease. The relation between trans fat intake and all-cause mortality has not been established.
OBJECTIVE: The aim of this study was to determine the relation between trans fat intake and all-cause mortality.
DESIGN: We used data from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study-a prospective cohort study of white and black men and women residing in the continental United States. Energy-adjusted trans fat intake was categorized into quintiles, and Cox-regression was used to evaluate the association between trans fat intake and all-cause mortality.
RESULTS: During 7 y of follow-up, there were 1572 deaths in 18,513 participants included in REGARDS. From the first to the fifth quintile of trans fat intake, the mortality rates per 1000 person-years of follow-up (95% CIs) were 12.8 (11.3, 14.5), 14.3 (12.7, 16.2), 14.6 (13.0, 16.5), 19.0 (17.1, 21.1), and 23.6 (21.5, 25.9), respectively. After adjustment for demographic factors, education, and risk factors for mortality, the HRs (95% CIs) for all-cause mortality were 1.00, 1.03 (0.86, 1.23), 0.98 (0.82, 1.17), 1.25 (1.05, 1.48), and 1.24 (1.05, 1.48), respectively (P-trend = 0.004). The population attributable risk due to trans fat intake was 7% (95% CI: 5%, 8%).
CONCLUSION: Higher trans fat intake is associated with an increased risk of all-cause mortality.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23553155      PMCID: PMC3628378          DOI: 10.3945/ajcn.112.049064

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  49 in total

1.  The reasons for geographic and racial differences in stroke study: objectives and design.

Authors:  Virginia J Howard; Mary Cushman; Leavonne Pulley; Camilo R Gomez; Rodney C Go; Ronald J Prineas; Andra Graham; Claudia S Moy; George Howard
Journal:  Neuroepidemiology       Date:  2005-06-29       Impact factor: 3.282

Review 2.  Nonsteroidal anti-inflammatory drugs and cancer prevention.

Authors:  J A Baron; R S Sandler
Journal:  Annu Rev Med       Date:  2000       Impact factor: 13.739

3.  Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.

Authors:  Larry B Goldstein; Cheryl D Bushnell; Robert J Adams; Lawrence J Appel; Lynne T Braun; Seemant Chaturvedi; Mark A Creager; Antonio Culebras; Robert H Eckel; Robert G Hart; Judith A Hinchey; Virginia J Howard; Edward C Jauch; Steven R Levine; James F Meschia; Wesley S Moore; J V Ian Nixon; Thomas A Pearson
Journal:  Stroke       Date:  2010-12-02       Impact factor: 7.914

4.  Comparison of serum albumin, serum C-reactive protein, and pulse wave velocity as predictors of the 4-year mortality of chronic hemodialysis patients.

Authors:  Nobuyuki Amemiya; Tetsuya Ogawa; Kuniaki Otsuka; Yoshitaka Ando; Kosaku Nitta
Journal:  J Atheroscler Thromb       Date:  2011-09-15       Impact factor: 4.928

5.  Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs.

Authors:  L A García-Rodríguez; C Huerta-Alvarez
Journal:  Epidemiology       Date:  2001-01       Impact factor: 4.822

Review 6.  Chronic inflammation and cancer.

Authors:  Emily Shacter; Sigmund A Weitzman
Journal:  Oncology (Williston Park)       Date:  2002-02       Impact factor: 2.990

7.  trans fatty acids and systemic inflammation in heart failure.

Authors:  Dariush Mozaffarian; Eric B Rimm; Irena B King; Richard L Lawler; George B McDonald; Wayne C Levy
Journal:  Am J Clin Nutr       Date:  2004-12       Impact factor: 7.045

8.  Association between family risk of stroke and myocardial infarction with prevalent risk factors and coexisting diseases.

Authors:  Richard E Kennedy; George Howard; Rodney C Go; Peter M Rothwell; Hemant K Tiwari; Rui Feng; Leslie A McClure; Ronald J Prineas; Amitava Banerjee; Donna K Arnett
Journal:  Stroke       Date:  2012-02-09       Impact factor: 7.914

9.  Trans fatty acids: are the effects only marginal?

Authors:  W C Willett; A Ascherio
Journal:  Am J Public Health       Date:  1994-05       Impact factor: 9.308

10.  Implications of increased C-reactive protein for cardiovascular risk stratification in black and white men and women in the US.

Authors:  Mary Cushman; Leslie A McClure; Virginia J Howard; Nancy S Jenny; Susan G Lakoski; George Howard
Journal:  Clin Chem       Date:  2009-07-30       Impact factor: 8.327

View more
  21 in total

Review 1.  Ischemic heart disease in women: a focus on risk factors.

Authors:  Puja K Mehta; Janet Wei; Nanette K Wenger
Journal:  Trends Cardiovasc Med       Date:  2014-10-16       Impact factor: 6.677

2.  Intake of polyunsaturated fat in relation to mortality among statin users and non-users in the Southern Community Cohort Study.

Authors:  J N Kiage; U K A Sampson; L Lipworth; S Fazio; G A Mensah; Q Yu; H Munro; E A Akwo; Q Dai; W J Blot; E K Kabagambe
Journal:  Nutr Metab Cardiovasc Dis       Date:  2015-07-29       Impact factor: 4.222

Review 3.  Dietary trans fatty acids and cardiovascular disease risk: past and present.

Authors:  Alice H Lichtenstein
Journal:  Curr Atheroscler Rep       Date:  2014-08       Impact factor: 5.113

Review 4.  [Lifestyle intervention in the primary prevention of cardiovascular diseases].

Authors:  Verena Heinicke; Martin Halle
Journal:  Herz       Date:  2020-02       Impact factor: 1.443

5.  Intake of trans fat and incidence of stroke in the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort.

Authors:  James N Kiage; Peter D Merrill; Suzanne E Judd; Ka He; Loren Lipworth; Mary Cushman; Virginia J Howard; Edmond K Kabagambe
Journal:  Am J Clin Nutr       Date:  2014-02-12       Impact factor: 7.045

6.  Diet pattern may affect fasting insulin in a large sample of black and white adults.

Authors:  Barbara A Gower; Keith Pearson; Nikki Bush; James M Shikany; Virginia J Howard; Caroline W Cohen; Stephanie E Tison; George Howard; Suzanne Judd
Journal:  Eur J Clin Nutr       Date:  2020-10-06       Impact factor: 4.016

7.  2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Donna K Arnett; Roger S Blumenthal; Michelle A Albert; Andrew B Buroker; Zachary D Goldberger; Ellen J Hahn; Cheryl Dennison Himmelfarb; Amit Khera; Donald Lloyd-Jones; J William McEvoy; Erin D Michos; Michael D Miedema; Daniel Muñoz; Sidney C Smith; Salim S Virani; Kim A Williams; Joseph Yeboah; Boback Ziaeian
Journal:  J Am Coll Cardiol       Date:  2019-03-17       Impact factor: 24.094

8.  2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Donna K Arnett; Roger S Blumenthal; Michelle A Albert; Andrew B Buroker; Zachary D Goldberger; Ellen J Hahn; Cheryl Dennison Himmelfarb; Amit Khera; Donald Lloyd-Jones; J William McEvoy; Erin D Michos; Michael D Miedema; Daniel Muñoz; Sidney C Smith; Salim S Virani; Kim A Williams; Joseph Yeboah; Boback Ziaeian
Journal:  J Am Coll Cardiol       Date:  2019-03-17       Impact factor: 24.094

Review 9.  2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Donna K Arnett; Roger S Blumenthal; Michelle A Albert; Andrew B Buroker; Zachary D Goldberger; Ellen J Hahn; Cheryl Dennison Himmelfarb; Amit Khera; Donald Lloyd-Jones; J William McEvoy; Erin D Michos; Michael D Miedema; Daniel Muñoz; Sidney C Smith; Salim S Virani; Kim A Williams; Joseph Yeboah; Boback Ziaeian
Journal:  Circulation       Date:  2019-03-17       Impact factor: 29.690

Review 10.  2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Donna K Arnett; Roger S Blumenthal; Michelle A Albert; Andrew B Buroker; Zachary D Goldberger; Ellen J Hahn; Cheryl Dennison Himmelfarb; Amit Khera; Donald Lloyd-Jones; J William McEvoy; Erin D Michos; Michael D Miedema; Daniel Muñoz; Sidney C Smith; Salim S Virani; Kim A Williams; Joseph Yeboah; Boback Ziaeian
Journal:  Circulation       Date:  2019-03-17       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.